23
09
2017

Resident Publication – Dr. Basile Tessier-Cloutier

Dr. Tessier-Cloutier and colleagues were published in BMC cancer for their article Programmed cell death ligand 1 cut-point is associated with disease specific survival in resected pancreatic ductal adenocarcinoma. In the study they explore the staining characteristics, prevalence and clinico-molecular correlates of programmed cell death 1 ligand overexpression in pancreatic ductal adenocarcinoma. Their data suggests that there is an inverse relationship between expression and disease specific survival times in resected pancreatic ductal adenocarcinoma.

Tags for this post

author: Michelle Seymour